OMIC(Delisted)
Singular Genomics (OMIC) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Singular Genomics market cap is -- and enterprise value is --.
Share Statistics
Singular Genomics has 2.54M shares outstanding, with a free float of 1.70M.
Valuation Ratios
Singular Genomics's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Singular Genomics debt-to-equity ratio is -- and debt-to-assets ratio is --.
Liquidity
Singular Genomics's current ratio is --, quick ratio is --, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
Singular Genomics's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
Singular Genomics gross margin is -50.77%, operating margin is -3487.21%, and net margin is -3236.67%.
Cost Structure
Singular Genomics spends 1630.30% of revenue on R&D and 1806.15% on SG&A.
Operating Efficiency
Singular Genomics's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Singular Genomics's revenue is --, gross profit is -1.35M, net income is --, and EBITDA is --.
Balance Sheet
Singular Genomics's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
Singular Genomics's operating cash flow is --, free cash flow is --, and CapEx is --.
Dividends & Yields
Singular Genomics dividend yield is --, with a payout ratio of 0.00% and dividend per share of --.
Analyst Rating
Singular Genomics's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A life science technology company that develops next-generation sequencing and multiomics technologies
Per Share Metrics
Singular Genomics's EPS is --, book value per share is --, and free cash flow per share is --.
